4//SEC Filing
Sniecinski Megan 4
Accession 0001127602-19-033033
CIK 0000882796other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:16 PM ET
Size
4.2 KB
Accession
0001127602-19-033033
Insider Transaction Report
Form 4
Sniecinski Megan
Chief Business Officer
Transactions
- Purchase
Common Stock
2019-11-18$1.45/sh+45,000$65,250→ 45,000 total
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001781480
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 4:16 PM ET
- Size
- 4.2 KB